Alzheimer’s Disease & Cognitive Disorders Symposium

The Future of Alzheimer’s Care Is Taking Shape.

Spend three focused days alongside leading experts exploring the advances reshaping Alzheimer’s care, from earlier diagnosis and biomarker use to emerging therapies and long-term disease management.

Dec 4–6, 2026
Orlando, FL Hyatt Regency Grand Cypress Resort
Marc Agronin Speaking at podium
Hyatt Regency Grand Cypress
Networking between colleagues
Colleagues looking at research
Attendee with a computer listening
  • 11.5 Credits Awarded for Attending
  • 3 Focused Days
  • 15+ Expert-Led Discussions

Education Built Around the Questions Clinicians are Facing Now

01

Earlier Recognition & Diagnosis

Explore evolving diagnostic frameworks, cognitive assessment, differential diagnosis, and earlier identification of disease.

02

Biomarkers in Practice

Examine how CSF, PET, and emerging blood-based biomarkers are influencing clinical evaluation and decision-making.

03

Treatment Decisions

Navigate current evidence, disease-modifying therapies, patient selection, monitoring, and real-world treatment considerations.

04

Beyond Alzheimer’s Disease

Strengthen your approach to the broader spectrum of dementias and the complex presentations encountered in clinical practice.

05

Long-Term Cognitive Care

Consider neuropsychiatric symptoms, caregiver support, risk reduction, progression, and longitudinal care planning.

06

Multidisciplinary Decisions

Learn across specialties and examine how coordinated care can support patients and caregivers throughout the disease continuum.

See How Three Days of Education Come Together in Orlando.

View the 2026 Agenda

Designed to Make a Difference

Hear directly from clinicians who have experienced ADCD for themselves.

  • I liked that the discussions went beyond the science and focused on the real decisions I need to make with both patients and their family.

    Jennifer Sanchez

  • The topics explored during the conference answered a lot of the questions I’ve been having as Alzheimer’s diagnosis and treatment continue to evolve. I am definitely taking this information back to my practice.

    Neel Singh

  • The sessions felt very connected to the challenges we’re seeing with patients right now. This is the kind of Alzheimer’s education I am looking for.

    Abigail Kaeser

Explore the Featured Speakers

View Faculty

Who Should Attend?

Designed for healthcare professionals across specialties to explore evolving approaches to neurologic and cognitive care.

Neurologists
Psychiatrists
Primary Care Providers
Geriatricians
Nurse Practitioners
Physician Associates
Nurses
The Essentials

What You Need to Know About ADCD

 

What is the Alzheimer’s Disease & Cognitive Disorders Symposium?

The Alzheimer’s Disease & Cognitive Disorders Symposium, or ADCD, is an in-person continuing education meeting for clinicians involved in Alzheimer’s disease, dementia, and cognitive care. The program focuses on practical education across diagnosis, biomarkers, treatment planning, neuropsychiatric symptom management, caregiver support, and multidisciplinary care.

When and where is ADCD Symposium 2026?

ADCD Symposium 2026 will take place December 4–6, 2026, at the Hyatt Regency Grand Cypress in Orlando, Florida.

What topics are covered at ADCD Symposium?

The program covers timely clinical topics across Alzheimer’s disease, dementia, and cognitive disorders, including diagnostic criteria, cognitive assessment, biomarkers, disease-modifying therapies, neuropsychiatric symptoms, risk reduction, caregiver support, shared decision-making, long-term care planning, and complex case management.

Is ADCD Symposium only for neurologists?

No. ADCD is intentionally multidisciplinary. Neurologists are an important part of the program, but the education also brings together psychiatry, geriatrics, primary care, advanced practice, nursing, and other professionals involved in Alzheimer’s disease and dementia care.

Why is ADCD Symposium relevant now?

Alzheimer’s disease and dementia care continue to change as diagnostic pathways evolve, biomarker use expands, new treatment considerations emerge, and care becomes increasingly multidisciplinary. ADCD is built to help clinicians examine those changes and translate them into real-world patient care.

Join Our Mailing List

Back to top